Correlation Between NRX Pharmaceuticals and Processa Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both NRX Pharmaceuticals and Processa Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NRX Pharmaceuticals and Processa Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NRX Pharmaceuticals and Processa Pharmaceuticals, you can compare the effects of market volatilities on NRX Pharmaceuticals and Processa Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NRX Pharmaceuticals with a short position of Processa Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of NRX Pharmaceuticals and Processa Pharmaceuticals.
Diversification Opportunities for NRX Pharmaceuticals and Processa Pharmaceuticals
0.53 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between NRX and Processa is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding NRX Pharmaceuticals and Processa Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Processa Pharmaceuticals and NRX Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NRX Pharmaceuticals are associated (or correlated) with Processa Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Processa Pharmaceuticals has no effect on the direction of NRX Pharmaceuticals i.e., NRX Pharmaceuticals and Processa Pharmaceuticals go up and down completely randomly.
Pair Corralation between NRX Pharmaceuticals and Processa Pharmaceuticals
Given the investment horizon of 90 days NRX Pharmaceuticals is expected to generate 0.59 times more return on investment than Processa Pharmaceuticals. However, NRX Pharmaceuticals is 1.7 times less risky than Processa Pharmaceuticals. It trades about -0.03 of its potential returns per unit of risk. Processa Pharmaceuticals is currently generating about -0.02 per unit of risk. If you would invest 390.00 in NRX Pharmaceuticals on September 14, 2024 and sell it today you would lose (271.00) from holding NRX Pharmaceuticals or give up 69.49% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
NRX Pharmaceuticals vs. Processa Pharmaceuticals
Performance |
| Timeline |
| NRX Pharmaceuticals |
| Processa Pharmaceuticals |
NRX Pharmaceuticals and Processa Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with NRX Pharmaceuticals and Processa Pharmaceuticals
The main advantage of trading using opposite NRX Pharmaceuticals and Processa Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NRX Pharmaceuticals position performs unexpectedly, Processa Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Processa Pharmaceuticals will offset losses from the drop in Processa Pharmaceuticals' long position.| NRX Pharmaceuticals vs. Biomx Inc | NRX Pharmaceuticals vs. Lexaria Bioscience Corp | NRX Pharmaceuticals vs. Aditxt Inc | NRX Pharmaceuticals vs. Nutriband |
| Processa Pharmaceuticals vs. Alpha Cognition | Processa Pharmaceuticals vs. Acurx Pharmaceuticals LLC | Processa Pharmaceuticals vs. Fennec Pharmaceuticals | Processa Pharmaceuticals vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |